ScholarIQanswers from OpenAlex & ORCID
Marjolijn van Buren
ResearcherPublications, citations & collaboration network
Marjolijn van Buren is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marjolijn van Buren have?
ScholarIQindexed works
Marjolijn van Buren has 131 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marjolijn van Buren have?
ScholarIQcitation count
Marjolijn van Buren has 3,177 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marjolijn van Buren?
ScholarIQh-index
Marjolijn van Buren has an h-index of 29 in OpenAlex.
What is the i10-index of Marjolijn van Buren?
ScholarIQi10-index
Marjolijn van Buren has an i10-index of 65 in OpenAlex.
What is the ORCID of Marjolijn van Buren?
ScholarIQorcid
The ORCID for Marjolijn van Buren is on the source record.
What is the OpenAlex record for Marjolijn van Buren?
ScholarIQopenalex
The OpenAlex for Marjolijn van Buren is on the source record.
What are the most-cited papers on Marjolijn van Buren?
ScholarIQmost cited works
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
Luuk B. Hilbrands, Raphaël Duivenvoorden, Priya Vart, Casper Franssen, Marc H. Hemmelder, Kitty J. Jager, Lyanne M. Kieneker, Marlies Noordzij, Michelle J. Pena, Hanne de Vries, David Arroyo, Adrian Covic, Marta Crespo, Éric Goffin, Mahmud İslam, Ziad A. Massy, Núria Montero, João Oliveira, Ana Roca Muñoz, J. Emilio Sánchez-Álvarez, Sivakumar Sridharan, Rebecca Winzeler, Ron T. Gansevoort, ERACODA Collaborators, Jeroen B. van der Net, Marie Essig, Peggy W G du Buf-Vereijken, Betty van Ginneken, Nanda Maas, Liffert Vogt, Brigit C. van Jaarsveld, Fréderike J. Bemelman, Farah Klingenberg-Salahova, Frederiek Heenan‐Vos, Marc Vervloet, Azam Nurmohamed, Daniel Abramowicz, Sabine Verhofstede, Omar Maoujoud, Jana Fialová, Edoardo Melilli, Àlex Favà, Josep M. Cruzado, Joy Lips, Maaike Hengst, Ryszard Gellert, Andrzej Rydzewski, Daniela G Alferes, Ivan Rychlík, Elena Zakharova, Patrice Max Ambuehl, Fanny Lepeytre, Clémentine Rabaté, Guy Rostoker, Sofia Marques, Tijana Azaševac, Dajana Katičić, Marc ten Dam, Thilo Krüger, S. J. J. Logtenberg, Lutz Fricke, Adriaan L Zanen, Jeroen J P Slebe, Delphine Kemlin, Jacqueline van de Wetering, Jaromír Eiselt, Lukáš Kielberger, Hala S El-Wakil, Samar Abd ElHafeez, C Canal, Carme Facundo, Ana Ramos, Alicja Dębska‐Ślizień, Nicoline M H Veldhuizen, Stylianos Panagoutsos, Irina Matceac, Ionuţ Nistor, Monica Cordos, J H M Groeneveld, Marjolijn van Buren, Fritz Diekmann, Ana Cristina Fernandes Maria Ferreira, Augusto César Soares dos Santos, Carlos Arias-Cabrales, Laura Llinàs-Mallol, Anna Buxeda, Carla Burballa Tàrrega, Dolores Redondo‐Pachón, María Dolores Arenas Jiménez, Julia M. Hofstra, Antonio Franco, María Luisa Rodríguez, Sagrario Balda Manzanos, Gabriel de Arriba, R. Haridian Sosa Barrios, Karlijn Bartelet, Erol Demir, Daan A M J Hollander, Angèle P. M. Kerckhoffs, Stefan Büttner
Functional and Cognitive Impairment, Frailty, and Adverse Health Outcomes in Older Patients Reaching ESRD—A Systematic Review
Marije H. Kallenberg, Hilda A. Kleinveld, Friedo W. Dekker, Barbara C. Van Munster, Ton J. Rabelink, Marjolijn van Buren, Simon P. Mooijaart
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal, on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Augusto Vallejos, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Richard J. MacIsaac, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Peter G. Colman, David Colquhoun, Chris Ellis, Kim Joshua, Eugenia Pedagogos, Paul Regal, Duncan J. Topliss, James Vandeleur, Johan Verjans, Gary Wittert, Katie-Jane Wynne, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer, Bernhard Paulweber, Rudolf Prager, Wolfgang Preiß, Friedrich C. Prischl, G. Schernthaner, Harald Sourij, Martin Wiesholzer, Heinz Drexel, Rainer Oberbauer, Hans‐Robert Schönherr, Peter Doubel, W. Engelen, Pieter Gillard, Jean‐Michel Hougardy, Jean-Marie Krzesinski, Bart Maes, Marijn M. Speeckaert, Koen Stas, Luc Van Gaal, Hilde Vanbelleghem, Francis Duyck, André Scheen, Daniela Antunes, Roberto Botelho, Cláudia Brito, Luís Henrique Santos Canani, Maria Eugênia Fernandes Canziani, Maria Cerqueira, Rogério de Paula, Freddy G. Eliaschewitz, Carlos Eduardo Poli‐de‐Figueiredo, Adriana Costa e Forti, Miguel Nasser Hissa, Maurilo Leite, Emerson de Lima, Irene L. Noronha, Bruno Paolino
Nurse Practitioner Care Improves Renal Outcome in Patients with CKD
Mieke J. Peeters, Arjan D. van Zuilen, Jan A.J.G. van den Brand, Michiel L. Bots, Marjolijn van Buren, Marc A G J ten Dam, Karin A. H. Kaasjager, Gerry Ligtenberg, Yvo W.J. Sijpkens, Henk E. Sluiter, Peter J.G. van de Ven, Gerald Vervoort, Louis‐Jean Vleming, Peter J. Blankestijn, Jack F.M. Wetzels
Validation of the kidney failure risk equation in European CKD patients
Michael J. Peeters, Arjan D. van Zuilen, Jan A.J.G. van den Brand, Michiel L. Bots, Peter J. Blankestijn, Jack F.M. Wetzels, for the MASTERPLAN Study Group, Peter J. Blankestijn, Michiel L. Bots, Marjolijn van Buren, Marc A G J ten Dam, Karin A. H. Kaasjager, Gerry Ligtenberg, Yvo W.J. Sijpkens, S. Henk E., P. J. G. van de Ven, Griet Vervoort, Louis Jean Vleming, Jack F.M. Wetzels, A. D. van Zuilen